This study of 250 IBS patients, compared two treatments: a diet low in fermentable carbohydrates (FODMAPs) and, secondly, medication otilonium bromide, which reduces spasms in the gastrointestinal tract.
In exactly the same way, this pioneering study suggests genetic variations in carbohydrate enzymes (hCAZymes) may affect how IBS patients respond to a low-carbohydrate diet (low-FODMAP).
Hope now comes in the form of a study showing how people with IBS respond to a low carbohydrate diet.
This could lead to tailored treatments for IBS, using genetic markers to predict which patients benefit from which diets.
Breakthrough for IBS sufferers with personalised diet tailored to their genes Treating irritable bowel syndrome is notoriously difficult because the cause is elusive.
